Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges

This study aims to highlight the cutting-edge approaches in cancer-gene editing therapy based on the CRISPR/Cas technology to target miRNAs in cancer therapy. Furthermore, we highlight the potential challenges in CRISPR/Cas-mediated miRNA gene editing and offer advanced strategies to overcome them.
Source: Military Medical Research - Category: International Medicine & Public Health Source Type: research